GLAZER CAPITAL, LLC

Holdings History for Drugs Made In America Acquisition Corp. - Ordinary Shares, $0.0001 par value (DMAA)

Symbol: DMAA on Nasdaq
Investment type: Equity / Ordinary Shares, $0.0001 par value
Latest Disclosed Shares Owned: 1,822,952 shares
Security Ownership %: 5.4%

Shares, Excluding Options vs Price

Value, Excluding Options

Glazer Capital, LLC ownership in Drugs Made In America Acquisition Corp. Ordinary Shares, $0.0001 par value (DMAA)

15 May 2025 - Glazer Capital, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,822,952 shares of Drugs Made In America Acquisition Corp. Ordinary Shares, $0.0001 par value (DMAA). This represents 5.4% ownership of the company. This is the first filing by GLAZER CAPITAL, LLC disclosing ownership of Drugs Made In America Acquisition Corp. Ordinary Shares, $0.0001 par value (DMAA).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Glazer Capital, LLC	5.4%		$18,338,897	1,822,952			$10.06	13G	31 Mar 2025	15 May 2025, 16:17

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.5%	-0%	$18,836,000	1,816,428	-5,864	-0.32%	$10.37	Q4 2025
30 Sep 2025	0.63%	-0%	$18,715,000	1,822,292	-158	-0.01%	$10.27	Q3 2025
30 Jun 2025	0.66%	-0%	$18,589,000	1,822,450	-502	-0.03%	$10.20	Q2 2025
31 Mar 2025	0.85%	+0.85%	$18,266,000	1,822,952	+1,822,952	NEW	$10.02	Q1 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.